400m live with hepatitis But don’t know

WITH some 400 million people around the world infected with hepatitis B or C, mostly without being aware, the United Nations top health agency encourages countries to boost testing and access to services and medicines for people in need to combat the “ignored perils” of this disease.

A staggering 95 percent of people infected with hepatitis B or C do not know they are infected, often living without symptoms for many years, the World Health Organisation (WHO) warns. And over 90 percent of people with hepatitis C can be completely cured within three to six months.

“The world has ignored hepatitis at its peril,” said Dr Margaret Chan, WHO’s director general, ahead of the World Hepatitis Day, which is observed annually on 28 July.

“It is time to mobilise a global response to hepatitis on the scale similar to that generated to fight other communicable diseases like HIV AIDS and tuberculosis,” she said.

The number grows by six to 10 million a year, WHO reported, while announcing plans to release new testing guidelines for both hepatitis B and C.

With this, among other actions, the Geneva-based World Health Organisation attempts “to encourage testing and reach the 95 percent of people who are not aware they are infected with the disease.”

The theme of this year’s World Hepatitis Day was Know Hepatitis; Act Now.

Together with its partner, Social Entrepreneurship for Sexual Health, WHO on July 25 said it recently launched #HepTestContest, a global contest to show how the testing guidelines could translate into real action on the ground.

“We needed examples of innovations and best practices to help guide and inspire others,” said Philippa Easterbrook from the WHO Global Hepatitis Programme, who co-led the project.

The contest received 64 contributions from 27 countries, WHO said.

Five finalists were selected by a panel of experts including representatives from WHO, the World Hepatitis Alliance and Médecins sans Frontières, who reviewed the testing models for innovation, effectiveness, and plans for sustainability.

In addition to national testing campaigns, approaches included testing in prisons, testing in the workplace and hospital emergency rooms, integrated HIV-hepatitis testing, as well as the use of internet, social media, and electronic medical records to flag higher-risk patients for testing in primary care.

“From prisons in Australia, use of an internetbased risk self-assessment tool in the Netherlands, community testing camps for drug users in India, to testing in primary care in Mongolia we learned some great lessons about how to build awareness of this hidden disease, improve testing rates and link those infected to treatment and care,” Philippa Easterbrook added.

An important feature of the approach was the strong community involvement and support as well as strategic partnerships to leverage reductions in the price of treatments, WHO said.

“Bringing together pharmaceutical companies, government, research organisations and communities to help negotiate price reductions make hepatitis treatments more affordable,” said Easterbrook.

“The contest demonstrated a range of possibilities. It showed that if we can develop acceptable testing approaches to suit different contexts and cultures, then we can increase effective hepatitis testing in more countries and communities,” she added.

In May of this year, the World Health Assembly —WHO’s decision-making body — called for treating eight million people for hepatitis B or C by 2020, to reduce new viral hepatitis infections by 90 percent, and to decrease the number of deaths by 65 percent in 2030, as compared with 2016. These targets are part of the first ever Global Health Sector Strategy on viral hepatitis. — IPS